Professor | Shibo Jiang | Asia Growth Partners

Name	Shibo Jiang
Contact Information	shibojiang@fudan.edu.cn
Language ability	Chinese, English
Province	Shanghai

Name

Shibo Jiang

Contact Information

shibojiang@fudan.edu.cn

Language ability

Chinese, English

Province

Shanghai

University/Lab Affiliation and Title	Fudan University
Faculty	Basic Medical Sciences
Academic Background & Achievements	1974.09—1978.06 Bachelor's Degree: Guangzhou First Military Medical University 1980.09—1983.06 Master's Degree in Immunology: Guangzhou First Military Medical University 1985.09—1987.06 Ph.D. in Microbiology: Xi'an Fourth Military Medical University
Work Experience	1978.07—1980.08 - Guangzhou First Military Medical University - Teaching Assistant in Microbiology and Immunology 1983.07—1985.08 - Guangzhou First Military Medical University - Lecturer in Immunology 1987.07—1990.02 - Rockefeller University, USA - Postdoctoral Researcher 1990.03—2010.10 - New York Blood Center LFK Institute, USA - Researcher/Laboratory Director 2010.10—Present - Fudan University - Professor at the Key Laboratory of Molecular Virology
Awards	2021: Fellow of the American Academy of Microbiology (AAM) 2021: Advanced Individual Award for Fighting COVID-19 in the National Science and Technology System, Ministry of Science and Technology of the People's Republic of China 2021: First Prize of Shanghai Science and Technology Progress Award (led by Zhang Wenhong): Emergency Application of Clinical Treatment and Innovative Technology for COVID-19 (Epidemic Prevention and Control) 2021: Silver Medal at the Geneva Invention Exhibition 2021: Outstanding Teacher Award of Fudan University Shanghai Medical College (Fudan-Fosun Health Dream Fund) for 2018/2019 2021: Sanofi-Cell Research Outstanding Paper Award 2020: Hu Xiaoyu Memorial Award at the 6th National Symposium on Peptide Drug Development and Large-Scale Production Frontier Technology 2020: Outstanding Contribution Award for Peptide Application at the 16th China International Peptide Symposium 2020: 9th 'Good Mentor in the Eyes of Graduate Students' Award of Fudan University 2019: Outstanding Product Award at the 21st China International High-Tech Achievements Fair 2015: Top Ten News Figures in Shanghai Education Annual 2013: 'Outstanding Contribution Award' and 'Outstanding Professor Award' of Fudan University Basic Medical College

University/Lab Affiliation and Title

Fudan University

Faculty

Basic Medical Sciences

Academic Background & Achievements

1974.09—1978.06 Bachelor's Degree: Guangzhou First Military Medical University
1980.09—1983.06 Master's Degree in Immunology: Guangzhou First Military Medical University
1985.09—1987.06 Ph.D. in Microbiology: Xi'an Fourth Military Medical University

Work Experience

1978.07—1980.08 - Guangzhou First Military Medical University - Teaching Assistant in Microbiology and Immunology
1983.07—1985.08 - Guangzhou First Military Medical University - Lecturer in Immunology
1987.07—1990.02 - Rockefeller University, USA - Postdoctoral Researcher
1990.03—2010.10 - New York Blood Center LFK Institute, USA - Researcher/Laboratory Director
2010.10—Present - Fudan University - Professor at the Key Laboratory of Molecular Virology

Awards

2021: Fellow of the American Academy of Microbiology (AAM)
2021: Advanced Individual Award for Fighting COVID-19 in the National Science and Technology System, Ministry of Science and Technology of the People's Republic of China
2021: First Prize of Shanghai Science and Technology Progress Award (led by Zhang Wenhong): Emergency Application of Clinical Treatment and Innovative Technology for COVID-19 (Epidemic Prevention and Control)
2021: Silver Medal at the Geneva Invention Exhibition
2021: Outstanding Teacher Award of Fudan University Shanghai Medical College (Fudan-Fosun Health Dream Fund) for 2018/2019
2021: Sanofi-Cell Research Outstanding Paper Award
2020: Hu Xiaoyu Memorial Award at the 6th National Symposium on Peptide Drug Development and Large-Scale Production Frontier Technology
2020: Outstanding Contribution Award for Peptide Application at the 16th China International Peptide Symposium
2020: 9th 'Good Mentor in the Eyes of Graduate Students' Award of Fudan University
2019: Outstanding Product Award at the 21st China International High-Tech Achievements Fair
2015: Top Ten News Figures in Shanghai Education Annual
2013: 'Outstanding Contribution Award' and 'Outstanding Professor Award' of Fudan University Basic Medical College

Areas of Focus	Mechanisms of enveloped virus entry into host cells and development of broad-spectrum virus entry inhibitors Development of broad-spectrum antiviral vaccines (including coronaviruses) Development of drugs and biological agents to prevent sexually transmitted viruses
Publications	Antivirals with common targets against highly pathogenic viruses, Lu L, Su S, Yang, H, Jiang S, 2021 Broad neutralization of SARS-CoV-2 variants by an inhalable bispecific single-domain antibody, Li C#, Zhan W#, Yang Z#, Tu C#, Zhu Y#, Song W, Huang K, Gu X, Kong Y, Zhang X, Zhang M, Zhang Y, Xie Y, Deng Q, Chen Z, Lu L, Jiang S, Sun L, Wu Y, Ying T, 2022 Don't rush to deploy COVID-19 vaccines and drugs without sufficient safety guarantees, Jiang S, 2020 HIV-1 inhibition by a peptide, Jiang, S., Lin, K., Strick, N., and Neurath, A.R., 1993 Pulmonary surfactant-mimetic nanoparticles for heterosubtypic immunity against influenza viruses, Wang, J.#, Li, P.#, Yu, Y., Fu, Y., Jiang, H., Lu, M., Sun, Z., Jiang, S., Lu, L., Wu, M.X., 2020 Adaptation of SARS-CoV-2 in BALB/c mice for testing vaccine efficacy, Gu H, Chen Q, Yang G, He L, Fan H, Deng Y, Wang Y, Teng Y, Zhao Z, Cui Y, Li Y, Li X, Li J, Zhang N, Yang X, Guo Y, Zhao G, Wang X, Luo DY, Wang H, Yang X, Li Y, Han G, He Y, Zhou X, Geng S, Sheng X, Jiang S, Sun S, Qin C, Zhou Y, 2020 Interaction between the heptad repeat 1 and 2 regions in spike protein of SARS-associated coronavirus: implication for virus fusogenic mechanism and identification of fusion inhibitors, Liu, S., Xiao, G., Chen, Y., He, Y., Niu, J., Escalante, C.R., Xiong, H., Farmar, J., Debnath, A.K., Tien, P., and Jiang, S., 2004 Learning from the past: development of safe and effective COVID-19 vaccines, Su S, Du L, Jiang S, 2021 The spike protein of SARS-CoV—a target for vaccine and therapeutic development, Du, L., He, Y., Zhou, Y., Liu, S., Zheng, B., Jiang, S., 2009 Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion, Xia S#, Liu M#, Wang C#, Xu W#, Lan Q, Feng S, Qi F, Bao L, Du L, Liu S, Qin C, Sun F, Shi Z, Zhu Y, Jiang S, Lu Lu*, 2020 Virus Entry Inhibitors, Jiang, S., Lu, L. (Ed.), 2022

Areas of Focus

Mechanisms of enveloped virus entry into host cells and development of broad-spectrum virus entry inhibitors
Development of broad-spectrum antiviral vaccines (including coronaviruses)
Development of drugs and biological agents to prevent sexually transmitted viruses

Publications

Antivirals with common targets against highly pathogenic viruses, Lu L, Su S, Yang, H, Jiang S*, 2021
Broad neutralization of SARS-CoV-2 variants by an inhalable bispecific single-domain antibody, Li C#, Zhan W#, Yang Z#, Tu C#, Zhu Y#, Song W, Huang K, Gu X, Kong Y, Zhang X, Zhang M, Zhang Y, Xie Y, Deng Q, Chen Z, Lu L, Jiang S, Sun L*, Wu Y*, Ying T*, 2022
Don't rush to deploy COVID-19 vaccines and drugs without sufficient safety guarantees, Jiang S, 2020
HIV-1 inhibition by a peptide, Jiang, S.*, Lin, K., Strick, N., and Neurath, A.R., 1993
Pulmonary surfactant-mimetic nanoparticles for heterosubtypic immunity against influenza viruses, Wang, J.#, Li, P.#, Yu, Y., Fu, Y., Jiang, H., Lu, M., Sun, Z., Jiang, S., Lu, L.*, Wu, M.X.*, 2020
Adaptation of SARS-CoV-2 in BALB/c mice for testing vaccine efficacy, Gu H, Chen Q, Yang G, He L, Fan H, Deng Y, Wang Y, Teng Y, Zhao Z, Cui Y, Li Y, Li X, Li J, Zhang N, Yang X, Guo Y, Zhao G, Wang X, Luo DY, Wang H, Yang X, Li Y, Han G, He Y, Zhou X, Geng S, Sheng X, Jiang S*, Sun S*, Qin C*, Zhou Y*, 2020
Interaction between the heptad repeat 1 and 2 regions in spike protein of SARS-associated coronavirus: implication for virus fusogenic mechanism and identification of fusion inhibitors, Liu, S., Xiao, G., Chen, Y., He, Y., Niu, J., Escalante, C.R., Xiong, H., Farmar, J., Debnath, A.K., Tien, P., and Jiang, S.*, 2004
Learning from the past: development of safe and effective COVID-19 vaccines, Su S, Du L, Jiang S*, 2021
The spike protein of SARS-CoV—a target for vaccine and therapeutic development, Du, L., He, Y., Zhou, Y., Liu, S., Zheng, B., Jiang, S.*, 2009
Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion, Xia S#, Liu M#, Wang C#, Xu W#, Lan Q, Feng S, Qi F, Bao L, Du L, Liu S, Qin C, Sun F*, Shi Z*, Zhu Y*, Jiang S*, Lu Lu*, 2020
Virus Entry Inhibitors, Jiang, S., Lu, L. (Ed.), 2022

Virus Entry Host Cells Broad-Spectrum Inhibitors Antiviral Vaccines Coronaviruses Sexually Transmitted Viruses Biological Agents Drug Development Immunology Microbiology

Chengpeng Fan - Wuhan University

Wenjun Guan - Zhejiang University

Jing Liu - Fudan University

View All

Personal Information

Academic Information

Research

Contact us

No account yet?

Personal Information

Academic Information

Research

Contact us